1. MicroRNA-based therapeutic strategies for chronic kidney disease and uremic cardiomyopathy
   Márta Sárközy et al, 2022, MicroRNA CrossRef
2. Rynchopeterine inhibits the formation of hypertrophic scars by regulating the miR-21/HIF1AN axis
   Wenbin Zhao et al, 2024, Experimental Cell Research CrossRef
3. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
   Rong Zheng et al, 2023, Open Medicine CrossRef
4. Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis
   Bochuan Deng et al, 2024, ACS Pharmacology & Translational Science CrossRef
5. Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation
   SiJin Li et al, 2023, Frontiers in Cardiovascular Medicine CrossRef